Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Mycoses in pediatric patients.

William J Steinbach¹, Thomas J Walsh

¹Department of Pediatrics, Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA. stein022@mc.duke.edu

Infectious Disease Clinics of North America

|September 21, 2006

Summary

Limited progress in treating invasive fungal infections necessitates understanding antifungal drug pharmacokinetics in children. New studies are expanding pediatric antifungal data for optimal dosing strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of Amphotericin B in Corneal Preservation Media After Extended Frozen Storage.

Cornea·2020

Same author

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2020

Same author

Testicular Mapping: A Roadmap to Sperm Retrieval in Nonobstructive Azoospermia?

The Urologic clinics of North America·2020

Same author

Management of osteoarticular fungal infections in the setting of immunodeficiency.

Expert review of anti-infective therapy·2020

Same author

Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Antimicrobial agents and chemotherapy·2020

Same author

Posaconazole Alone and in Combination with Caspofungin for Treatment of Experimental <i>Exserohilum rostratum</i> Meningoencephalitis: Developing New Strategies for Treatment of Phaeohyphomycosis of the Central Nervous System.

Journal of fungi (Basel, Switzerland)·2020

Area of Science:

Medical Science
Pharmacology
Pediatrics

Background:

Limited progress in invasive fungal infection treatment for over 40 years.
Antifungal drug selection involves complex considerations regarding safety, tolerability, and pharmacokinetics.
Pediatric invasive fungal infections require specialized knowledge due to pharmacokinetic differences between children and adults.

Purpose of the Study:

To highlight the importance of understanding pharmacokinetic differences in pediatric antifungal drug management.
To address the scarcity of antifungal studies conducted specifically in children.
To emphasize the need for developing optimal pediatric dosing strategies based on robust data.

Main Methods:

Review of existing literature on antifungal agents, safety, tolerability, and pharmacokinetics.
Analysis of challenges in extrapolating adult data to pediatric populations.
Identification of the expanding body of antifungal data in children through ongoing research.

Main Results:

Significant advantages in understanding antifungal drug properties, but limited progress in treatment efficacy.
Most pediatric antifungal information is currently extrapolated from adult studies.
Newer studies are beginning to expand the breadth of antifungal data in children.

Conclusions:

Optimal management of pediatric invasive fungal infections hinges on understanding drug pharmacokinetics in this population.
Further dedicated clinical studies are crucial for establishing pediatric-specific indications and dosing.
Collaborative efforts are essential to advance pediatric antifungal therapy and benefit young patients.

Related Experiment Videos